Corpus Intelligence IC Memo — SISTERSVILLE GENERAL HOSPITAL 2026-04-26 12:28 UTC
IC Memo — SISTERSVILLE GENERAL HOSPITAL
Investment Committee Memorandum | WV | 6 beds | Grade C | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SISTERSVILLE GENERAL HOSPITAL

CCN 511304 | nan, WV | 6 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SISTERSVILLE GENERAL HOSPITAL is a 6-bed suburban community hospital in nan, WV with $16.9M in net patient revenue and a 2.4% operating margin. The hospital serves a payer mix of 41.4% Medicare, 9.4% Medicaid, and 49.2% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.4% to 9.7% (+736bps).

Net Revenue HCRIS$16.9M
Current EBITDA COMPUTED$402K
Operating Margin COMPUTED2.4%
Occupancy HCRIS50.2%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS83.0%
Distress Probability ML53.2%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
114
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 2.4% places it above the state median. Among 114 size-comparable peers (3-12 beds), the median margin is -8.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (3-12), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SISTERSVILLE GENERAL HOSPITAL (Target)WV6$16.9M2.4%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
OCONTO HOSPITAL & MEDICAL CENTWI10$80.4M1.1%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
PHYSICIANS MEDICAL CENTERIN10$60.0M24.9%
SAMUEL SIMMONDS MEMORIAL HOSPIAK10$57.8M-50.0%
INSTITUTE FOR ORTHOPAEDIC SURGOH12$55.6M39.5%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$356K+210bp18mo
Cost to Collect4.5%2.5%$339K+200bp12mo
Denial Rate Reduction12.0%6.5%$335K+198bp12mo
A/R Days Reduction5200.0%3800.0%$206K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$356K
Cost to Collect
$339K
Denial Rate Reduction
$335K
A/R Days Reduction
$206K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.2M
Current EBITDA$402K
+ RCM Uplift+$1.2M
Pro Forma EBITDA$1.6M
Current Margin2.4%
Pro Forma Margin9.7%
WC Released (1x)$649K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$619K$15.1M24.42x89.5%
Base (11x exit)10.0x11.0x$619K$16.8M27.18x93.6%
Bull Case9.0x11.0x$557K$21.1M37.95x106.9%
Bull (12x exit)9.0x12.0x$557K$23.2M41.69x110.9%
Bear Case11.0x10.0x$681K$8.7M12.75x66.4%
Bear (11x exit)11.0x11.0x$681K$9.8M14.35x70.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 53.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 3-12 beds
  • Same-state prioritization (n=4)
  • Comp margins: P25=-22.5% / P50=-8.7% / P75=2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.